Functional assays in vitro and in vivo demonstrate that IMP2 suppresses cell migration and invasion in ccRCC by binding to and stabilizing the mRNA of creatine kinase B (CKB), thereby enhancing its expression. The gene discussed is CKB; the disease is nonpapillary renal cell carcinoma.